» Articles » PMID: 11850814

Inhibition of HOS Expression and Activities by Wnt Pathway

Overview
Journal Oncogene
Date 2002 Feb 19
PMID 11850814
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

BetaTrCP and HOS are closely related F-box proteins, which play key roles in ubiquitination and degradation of beta-catenin and IkappaB through associating with those phosphorylated substrates and recruiting SCF E3 ubiquitin ligase. Here we report that activation of Wnt/beta-catenin signal transduction pathway elevates betaTrCP levels but inhibits expression of HOS in 293T cells. Similar disparity is likely to exist in human colorectal tumors. In the NIH3T3 cells, which express HOS, but not betaTrCP, Wnt/beta-catenin signaling leads to inhibition of HOS promoter activity and NF-kappaB-driven transcription as well as to stabilization of beta-catenin. These results indicate that expression and activities of HOS are negatively regulated by Wnt/beta-catenin pathway.

Citing Articles

Beta-Transducin Repeats-Containing Proteins as an Anticancer Target.

Kim D, Yi Y, Seong Y Cancers (Basel). 2023; 15(17).

PMID: 37686524 PMC: 10487276. DOI: 10.3390/cancers15174248.


The Dynamic Change of Gene-Regulated Networks in Cashmere Goat Skin with Seasonal Variation.

Hu S, Li C, Wu D, Huo H, Bai H, Wu J Biochem Genet. 2021; 60(2):527-542.

PMID: 34304316 DOI: 10.1007/s10528-021-10114-2.


SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression.

Fukushima H, Ogura K, Wan L, Lu Y, Li V, Gao D Cell Rep. 2013; 4(4):803-16.

PMID: 23972993 PMC: 3839583. DOI: 10.1016/j.celrep.2013.07.031.


Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions.

Noubissi F, Nikiforov M, Colburn N, Spiegelman V Genes Cancer. 2011; 1(10):1074-82.

PMID: 21779431 PMC: 3092266. DOI: 10.1177/1947601910395581.


Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.

Syed D, Afaq F, Maddodi N, Johnson J, Sarfaraz S, Ahmad A J Invest Dermatol. 2011; 131(6):1291-9.

PMID: 21346776 PMC: 3166244. DOI: 10.1038/jid.2011.6.